Cart
sales@molnova.com
Home - Products - Immunology/Inflammation - Lipoxygenase - CAY10698

CAY10698

CAS No. 684236-01-9

CAY10698( —— )

Catalog No. M24698 CAS No. 684236-01-9

CAY10698 is a 12-lipoxygenase inhibitor (12-LO; IC50 of 5.1 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 In Stock
5MG 77 In Stock
10MG 128 In Stock
25MG 259 In Stock
50MG 403 In Stock
100MG 592 In Stock
500MG 1242 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    CAY10698
  • Note
    Research use only, not for human use.
  • Brief Description
    CAY10698 is a 12-lipoxygenase inhibitor (12-LO; IC50 of 5.1 μM).
  • Description
    CAY10698 is a 12-lipoxygenase inhibitor (12-LO; IC50 of 5.1 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    12-lipoxygenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    684236-01-9
  • Formula Weight
    391.47
  • Molecular Formula
    C17H17N3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:20.0 mg/mL
  • SMILES
    COC1=CC=CC(=C1O)CNC2=CC=C(C=C2)S(=O)(=O)NC3=NC=CS3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chen, X.-S., Kurre, U., Jenkins, N.A., et al. cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J. Biol. Chem. 269(19), 13979-13987 (1994
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • PXS-6302 hydrochlori...

    PXS-6302 hydrochloride is a potent irreversible lysine oxidase (LOX) inhibitor, inhibiting Bovine LOX, rh LOXL1, rh LOXL2, rh LOXL3, and rh LOXL4 with IC50 of 3.7 μM, 3.4 μM, 0.4 μM, 1.5 μM, and 0.3 μM, respectively.

  • ER-34122

    ER-34122, a novel orally available dual 5-lipoxygenase/cyclooxygenase inhibitor, exhibits potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.

  • Utreloxastat

    Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis .

Sign In Join Free